Verteporfin with altered (delayed) light in occult CNV (VALIO) - Results of a phase II controlled clinical trial

被引：0
|
作者：
Slakter, JS
Rosenfeld, PJ
机构：
[1] Bascom Palmer Eye Inst, Miami, FL 33136 USA
[2] Vitreous Ret Mac Consult NY, New York, NY USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2003年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1101
引用
收藏
页码：U297 / U297
页数：1
相关论文
共 50 条
  • [31] NEON ION RADIOTHERAPY - RESULTS OF THE PHASE-I/II CLINICAL-TRIAL
    LINSTADT, DE
    CASTRO, JR
    PHILLIPS, TL
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 20 (04): : 761 - 769
  • [32] Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial
    Klein, Allan L.
    Lin, David
    Cremer, Paul C.
    Nasir, Saifullah
    Luis, Sushil Allen
    Abbate, Antonio
    Ertel, Andrew
    LeWinter, Martin
    Beutler, Anna
    Fang, Fang
    Paolini, John F.
    HEART, 2021, 107 (06) : 488 - 496
  • [33] Choroideremia Gene Therapy Phase II Clinical Trial: 6-Month Results
    Lam, Byron L.
    Verriotto, Jennifer
    Gregori, Ninel
    Davis, Janet L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [34] GABAPENTIN FOR PAIN IN SICKLE CELL DISEASE: RESULTS OF A RANDOMIZED PHASE II CLINICAL TRIAL
    Puri, Latika
    Anghelescu, Doralina
    Hankins, Jane
    Nottage, Kerrie
    Wang, Winfred
    Kang, Guolian
    Gossett, Jefferey
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [35] Intravitreal Sirolimus for the Treatment of Geographic Atrophy: Results of a Phase I/II Clinical Trial
    Petrou, Philip A.
    Cunningham, Denise
    Shimel, Katherine
    Harrington, Molly
    Hammel, Keri
    Cukras, Catherine A.
    Ferris, Frederick L.
    Chew, Emily Y.
    Wong, Wai T.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (01) : 330 - 338
  • [36] Daclizumab phase II trial in relapsing and remitting multiple sclerosis - MRI and clinical results
    Rose, J. W.
    Burns, J. B.
    Bjorklund, J.
    Klein, J.
    Watt, H. E.
    Carlson, G.
    NEUROLOGY, 2007, 69 (08) : 785 - 789
  • [37] Daclizumab phase I/II trial in relapsing and remitting MS: MRI and clinical results
    Rose, J
    Burns, J
    Bjorklund, J
    Klein, J
    Watt, H
    Carlson, N
    MULTIPLE SCLEROSIS, 2005, 11 : S155 - S156
  • [38] Results of the first phase I/II clinical vaccination trial with direct injection of mRNA
    Weide, Benjamin
    Carralot, Jean-Philippe
    Reese, Anne
    Scheel, Birgit
    Eigentler, Thomas Kurt
    Hoerr, Ingmar
    Rammensee, Hans-Georg
    Garbe, Claus
    Pascolo, Steve
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (02) : 180 - 188
  • [39] RMPT in Relapsed/Refractory Multiple Myeloma: Results of a Multicenter Phase II Clinical Trial
    Palumbo, A.
    Larocca, A.
    Sanpaolo, G.
    Falcone, A. P.
    Federico, V.
    Canepa, L.
    Crugnola, M.
    Baldini, L.
    Magarotto, V.
    Falco, P.
    Petrucci, M. T.
    Boccadoro, M.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S14 - S15
  • [40] A randomized controlled trial with bright light and melatonin for delayed sleep phase disorder: Effects on subjective and objective sleep
    Saxvig, Ingvild West
    Wilhelmsen-Langeland, Ane
    Pallesen, Stale
    Vedaa, Oystein
    Nordhus, Inger Hilde
    Bjorvatn, Bjorn
    CHRONOBIOLOGY INTERNATIONAL, 2014, 31 (01) : 72 - 86
12345